ClinicalTrials.gg
CompletedNCT06252714Updated Jan 29, 2026

Impact of Defecation Posture on Ease of Bowel Movements in Patients With a Rectocele

An interventional study of Defecation Posture Modification Device in Pelvic Organ Prolapse, Rectocele and Bowel Dysfunction, sponsored by TriHealth Inc.. Completed at 3 sites in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-29.

Sponsored by TriHealth Inc. · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was Sep 2025, 1 year 2 months ago, and no results have been posted to the registry.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

The study aims to determine if defecation posture, when using a defecation posture modification device (DPMD), will improve ease of bowel movements in patients with pelvic organ prolapse, specifically rectoceles.

02

Conditions studied

  • Pelvic Organ Prolapse
  • Rectocele
  • Bowel Dysfunction

Keywords

  • defecation posture modification device
  • defecation posture
03

In context

Pelvic Organ Prolapse

521 studies on the registry are indexed under Pelvic Organ Prolapse; 80 are open to participants now.

This study's enrollment of 60 is below the median of 80 across 336 interventional studies indexed under Pelvic Organ Prolapse.

Browse Pelvic Organ Prolapse studies →

Lead sponsor

TriHealth Inc. is the lead sponsor of 102 studies on the registry; 9 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 4 (44%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with pelvic organ prolapse, including a rectocele (posterior compartment measurements to Stage 2 or greater) that endorse bowel dysfunction, based on our office standard screening questionnaires

Exclusion criteria

Exclusion Criteria:

  • Anyone currently using a defecation posture modification device Unwillingness or unable to participate in the study Planned travel, inability to use device during the study period Patient preparing to undergo pelvic reconstructive surgery prior to the end of the study period Presence of ileostomy/colostomy Bowel disease such as Crohn's disease or Ulcerative Colitis Daily opiate use Wheelchair bound If device may pose fall or safety hazard risk to patient, such as need for walker or cane for ambulation.

Patients weighing over 250 lbs, per manufacturer guidelines for the device Inability to understand English Pregnant women

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Defecation Posture Modification Device

    Patients will be given a Squatty Potty Device

    Device: Defecation Posture Modification Device

Interventions

  • DeviceDefecation Posture Modification Device

    Patients will be asked to use the defecation posture modification device with each bowel movement for two weeks.

    Also known as: Squatty potty

06

What researchers measure

Primary outcomes

  1. Straining with bowel movements

    Patients will assess straining with bowel movement on a 0 -10 numeric scale. The scale is called straining or ease with bowel movements. The number 0 indicates no straining and the number 10 indicates maximal straining with bowel movement.

    Time frame: 2 weeks

Secondary outcomes

  1. Colorectal-Anal Distress Inventory 8

    validated questionnaire to assess bowel function. The colorectal-anal distress inventory 8 is a validated questionnaire that asks 8 questions regarding bowel movements. The question is a YES or NO question. If they respond with YES, they respond with how bothersome they symptoms are. The scale is 1-4 with the number 1 being not at all bothersome and the number 4 being quite a bit bothersome.

    Time frame: 2 weeks

  2. Consistency of stool

    Bristol stool scale will be used to describe stool consistency. The Bristol stool scale is rated on Type 1- Type 7 describing the consistency of stool. Type 1 is hard lumps ranging to Type 7 which describes entirely watery and liquid stool. The patient is provided with a visual scale to help assist in answering the questions.

    Time frame: 2 weeks

  3. Use of laxative medication

    patients will log any laxative medication used

    Time frame: 2 weeks

  4. Ease of device use

    patients will be asked questions regarding satisfaction with and ease of use of device. When asked regarding satisfaction of the device they are asked on an 11 point numeric scale with 0 being not satisfied and 10 being very satisfied.

    Time frame: 2 weeks

07

Study locations

3 sites
  • Cincinnati Urogynecology Associates
    Cincinnati, Ohio 45220, United States
  • Good Samaritan Hospital
    Cincinnati, Ohio 45220, United States
  • Bethesda North Hospital
    Cincinnati, Ohio 45242, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06252714
Lead sponsor
TriHealth Inc.
Responsible party
Sponsor
First posted
Feb 12, 2024
Start date
Mar 1, 2024
Primary completion
Sep 1, 2025
Completion
Oct 1, 2025
Last update
Jan 29, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion